|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0200760,
umls-concept:C0220901,
umls-concept:C0334094,
umls-concept:C0441655,
umls-concept:C0449258,
umls-concept:C0521447,
umls-concept:C0699885,
umls-concept:C1424697,
umls-concept:C1519839,
umls-concept:C1522609,
umls-concept:C1554112
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-12-11
|
|
pubmed:abstractText |
To analyze the predictive power of Ki67 area% (Ki67), mitotic activity index (MAI), p53 area% (p53), and the mean area of the 10 largest nuclei (MNA10) for progression of stage in 195 primary consecutive TaT1 urothelial cell carcinomas of the urinary bladder.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1124-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12475695-Adult,
pubmed-meshheading:12475695-Aged,
pubmed-meshheading:12475695-Aged, 80 and over,
pubmed-meshheading:12475695-Biological Markers,
pubmed-meshheading:12475695-Carcinoma, Transitional Cell,
pubmed-meshheading:12475695-Carcinoma in Situ,
pubmed-meshheading:12475695-Cell Division,
pubmed-meshheading:12475695-Cell Nucleus,
pubmed-meshheading:12475695-Disease Progression,
pubmed-meshheading:12475695-Disease-Free Survival,
pubmed-meshheading:12475695-Humans,
pubmed-meshheading:12475695-Immunohistochemistry,
pubmed-meshheading:12475695-Ki-67 Antigen,
pubmed-meshheading:12475695-Middle Aged,
pubmed-meshheading:12475695-Mitotic Index,
pubmed-meshheading:12475695-Multivariate Analysis,
pubmed-meshheading:12475695-Neoplasm Staging,
pubmed-meshheading:12475695-Prognosis,
pubmed-meshheading:12475695-Risk Factors,
pubmed-meshheading:12475695-Tumor Suppressor Protein p53,
pubmed-meshheading:12475695-Urinary Bladder Neoplasms
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
|
|
pubmed:affiliation |
Department of Pathology, SIR Hospital, Stavanger, Norway.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
